Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,035.20
(
-0.49%
)
Dow Jones
50,644.28
(
0.00%
)
Brent Oil
94.78
(
2.53%
)
Bitcoin
73,356.51
(
-2.04%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123029
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 156126

Wednesday, 02/06/2013 1:11:10 PM

Wednesday, February 06, 2013 1:11:10 PM

Post# of 257648
4Q12 annualized Botox sales were $1.9B (!), which means that Botox outsold Dysport by 6.4:1 during the period:

http://seekingalpha.com/article/1158101-allergan-management-discusses-q4-2012-results-earnings-call-transcript

Worldwide, 52% of Botox sales were therapeutic, 48% cosmetic.

p.s. Annualizing Botox sales is slightly misleading due to seasonal strength in Q2 and Q4.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up